Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-

Bornhaeuser M, Schliemann C, Schetelig J, Rollig C, Kramer M, Glass B, Platzbecker U, Burchert A, Haenel M, Mueller LP, Klein S, Bug G, Rösler W, Roesler W, Schaefer-Eckart K, Schmid C, Jost E, Lenz G, Tischer J, Spiekermann K, Pfirrmann M, Serve H, Stoelzel F, Alakel N, Ehninger G, Berdel WE, Stelljes M (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2021-145167

Authors with CRIS profile

Involved external institutions

Universitätsklinikum Münster Germany (DE) Westfälische Wilhelms-Universität (WWU) Münster Germany (DE) Ludwig-Maximilians-Universität (LMU) Germany (DE) Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP) France (FR) Universitätsklinikum Augsburg Germany (DE) Technische Universität Dresden Germany (DE) Klinikum Chemnitz Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU) Germany (DE) Philipps-Universität Marburg Germany (DE) Universitätsklinikum Aachen (UKA) Germany (DE) Klinikum der Universität München (Großhadern und Innenstadt) Germany (DE) Universitätsklinikum Mannheim Germany (DE) Goethe-Universität Frankfurt am Main Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) Universitätsklinikum Leipzig Germany (DE) Paracelsus Medizinische Privatuniversität, Nürnberg Germany (DE) Universität Duisburg-Essen (UDE) Germany (DE) HELIOS Kliniken Germany (DE)

How to cite

APA:

Bornhaeuser, M., Schliemann, C., Schetelig, J., Rollig, C., Kramer, M., Glass, B.,... Stelljes, M. (2021). Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-. In BLOOD. WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Bornhaeuser, Martin, et al. "Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2021.

BibTeX: Download